Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.

Marianne ZiolNicolas PotéGiuliana AmaddeoAlexis LaurentJean-Charles NaultFrédéric ObertiCharlotte CostentinSophie MichalakMohamed BouattourClaire FrancozGeorges Philippe PageauxJeanne RamosThomas DecaensAlain LucianiBoris GuiuValérie VilgrainChristophe AubéJonathan DermanCécile CharpyJessica Zucman-RossiNathalie BargetOlivier SerorNathalie Ganne-CarriéValérie ParadisJulien Calderaro

Published in: Hepatology (Baltimore, Md.) (2018)

The MTM-HCC subtype, reliably observed in 12% of patients eligible for curative treatment, represents an aggressive form of HCC that may require more specific therapeutic strategies. (Hepatology 2018;68:103-112).

Keyphrases

end stage renal disease
prognostic factors
ejection fraction
newly diagnosed
chronic kidney disease
rectal cancer
patient reported outcomes